JA
Jill Ann Howe bought $17K of LCTX stock
Jill Ann Howe, Chief Financial Officer of Lineage Cell Therapeutics, Inc. (LCTX), bought 20,000 shares of LCTX stock worth $17K, per an SEC Form 4 filed Nov 16, 2026.
It was an open-market purchase.
The trade was reported on Nov 16, 2026.
LCTX has moved +3.1% since the trade date, from $0.80 to $0.82 (Nov 19, 2026 close).
- Traded
- Nov 16, 2026
- Disclosed
- Nov 16, 2026
- Filing delay
- 0 days
- Price since
- +3.1%
- Role
- Chief Financial Officer
- Source
- SEC Form 4